Pacira BioSciences Inc
NASDAQ:PCRX 3:59:13 PM EDT
| Market Cap (Intraday) | 3.09B |
| Current PE | 21.26 |
| Forward PE | 20.75 |
| 2yr Forward PE | 16.56 |
| 10-Day MA | $71.42 |
| 50-Day MA | $70.14 |
| 200-Day MA | $59.49 |
Pacira Biosciences, Inc. Stock, NASDAQ:PCRX
5 Sylvan Way, Suite 300, Parsippany, New Jersey 07054
Phone: +1.973.254.3560
Number of Employees: 606
Description
Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.